A detailed history of Aldebaran Capital, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Aldebaran Capital, LLC holds 438,252 shares of PMVP stock, worth $723,115. This represents 0.6% of its overall portfolio holdings.

Number of Shares
438,252
Previous 351,243 24.77%
Holding current value
$723,115
Previous $569 Million 14.76%
% of portfolio
0.6%
Previous 0.53%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.44 - $1.69 $125,292 - $147,045
87,009 Added 24.77%
438,252 $653 Million
Q2 2024

Aug 13, 2024

BUY
$1.51 - $2.21 $530,376 - $776,247
351,243 New
351,243 $569 Million

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $75.3M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Aldebaran Capital, LLC Portfolio

Follow Aldebaran Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aldebaran Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aldebaran Capital, LLC with notifications on news.